Associate Professor Mateusz Tajstra
Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator
Event: EHRA 2024
Topic: Radiotherapy
Session: Ventricular tachycardia 4
Remote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure and implanted cardioverter-defibrillator or cardiac resynchronization therapy.
Event: EHRA 2019
Topic: Home and Remote Patient Monitoring
Session: Late-breaking trials 2
Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.
Event: ESC Congress 2018
Topic: Outcome
Session: Outcome of coronary stenting up to 10 years
Comparison of long-term mortality of hybrid coronary revascularization vs. coronary artery bypass grafting. Three-years mortality of Hybrid Revascularization for Multivessel Coronary Artery Disease (H
Event: ESC Congress 2016
Topic: Minimally invasive and robotic surgery
Session: PCI and more
Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization device and defibrillator (CRT-D).
Event: ESC Congress 2016
Topic: Automatic implantable cardioverter / defibrillator
Session: Prevention sudden cardiac death and ICD therapy
ESC 365 is supported by
